Bronstein, Gewirtz & Grossman, LLC Is Investigating AlloVir Inc. (ALVR) And Encourages Investors to Connect

Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of investors who purchased AlloVir Inc. (NASDAQ:ALVR) securities before March 22, 2022. The investigation focuses on possible corporate wrongdoing by AlloVir and its officers or directors. Investors are encouraged to assist the investigation by visiting bgandg.com/ALVR. The firm operates on a contingency fee basis, meaning they only charge if successful in recovering funds for investors. Bronstein, Gewirtz & Grossman is known for representing investors in securities fraud cases.

NEW YORK, NY / ACCESS Newswire / June 17, 2025 / Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of AlloVir Inc. ("AlloVir" or "the Company") (NASDAQ:ALVR). Investors who purchased AlloVir securities prior to March 22, 2022, and continue to hold to the present, are encouraged to obtain additional information and assist the investigation by visiting the firm's site: bgandg.com/ALVR.

Investigation Details

The investigation concerns whether AlloVir and certain of its officers and/or directors have engaged in corporate wrongdoing.

What's Next?

If you are aware of any facts relating to this investigation or purchased AlloVir shares, you can assist this investigation by visiting the firm's site: bgandg.com/ALVR. You can also contact Peretz Bronstein or his client relations manager, Nathan Miller, of Bronstein, Gewirtz & Grossman, LLC:

There is No Cost to You

We represent investors in class actions on a contingency fee basis. That means we will ask the court to reimburse us for out-of-pocket expenses and attorneys' fees, usually a percentage of the total recovery, only if we are successful.

Why Bronstein, Gewirtz & Grossman

Bronstein, Gewirtz & Grossman, LLC is a nationally recognized firm that represents investors in securities fraud class actions and shareholder derivative suits. Our firm has recovered hundreds of millions of dollars for investors nationwide.

Attorney advertising. Prior results do not guarantee similar outcomes.

Contact

Bronstein, Gewirtz & Grossman, LLC

Peretz Bronstein or Nathan Miller

SOURCE: Bronstein, Gewirtz & Grossman, LLC

View the original press release on ACCESS Newswire